Targeting gene mutations to treat ovarian cancers
(Westmead Institute for Medical Research) New research has shown that ovarian cancer patients with a tumour mutation in the BRAF gene respond exceptionally well to treatment with targeted drugs, known as BRAF inhibitors.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Cancer | Cancer & Oncology | Genetics | International Medicine & Public Health | Ovarian Cancer | Ovaries | Research